Response to Nahshon and Lavie
J Natl Cancer Inst
.
2022 Feb 7;114(2):322-323.
doi: 10.1093/jnci/djab155.
Authors
Cornelis D de Kroon
1
,
Marthe M de Jonge
2
,
Tjalling Bosse
2
,
Christi J van Asperen
3
Affiliations
1
Department of Gynecology, Leiden University Medical Center, Leiden, the Netherlands.
2
Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
3
Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
PMID:
34424271
PMCID:
PMC8826548
DOI:
10.1093/jnci/djab155
No abstract available
Publication types
Comment
MeSH terms
BRCA1 Protein
BRCA2 Protein
Cohort Studies
Endometrial Neoplasms*
Female
Germ Cells
Humans
Mutation
Substances
BRCA1 Protein
BRCA1 protein, human
BRCA2 Protein
BRCA2 protein, human